These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33156099)

  • 1. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Chaparro M; Gordillo J; Domènech E; Esteve M; Barreiro-de Acosta M; Villoria A; Iglesias-Flores E; Blasi M; Naves JE; Benítez O; Nieto L; Calvet X; García-Sánchez V; Villagrasa JR; Marin AC; Donday MG; Abad-Santos F; Gisbert JP
    Am J Gastroenterol; 2020 Nov; 115(11):1802-1811. PubMed ID: 33156099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial.
    Raven SFH; Hoebe CJPA; Vossen ACTM; Visser LG; Hautvast JLA; Roukens AHE; van Steenbergen JE
    Lancet Infect Dis; 2020 Jan; 20(1):92-101. PubMed ID: 31629649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial.
    Etzion O; Novack V; Perl Y; Abel O; Schwartz D; Munteanu D; Abufreha N; Ben-Yaakov G; Maoz ED; Moshaklo A; Dizingf V; Fich A
    J Crohns Colitis; 2016 Aug; 10(8):905-12. PubMed ID: 26928962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease.
    Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
    Inflamm Bowel Dis; 2013 Mar; 19(3):554-8. PubMed ID: 23380936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
    Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
    Am J Gastroenterol; 2012 Oct; 107(10):1460-6. PubMed ID: 23034605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.
    Gisbert JP; Menchén L; García-Sánchez V; Marín I; Villagrasa JR; Chaparro M
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1379-85. PubMed ID: 22530631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule.
    de Vries-Sluijs TEMS; Andrinopoulou ER; de Man RA; van der Ende ME
    Neth J Med; 2020 Dec; 78(6):376-380. PubMed ID: 33380535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination.
    Lin CS; Xie SB; Liu J; Zhao ZX; Chong YT; Gao ZL
    Clin Vaccine Immunol; 2010 Oct; 17(10):1548-51. PubMed ID: 20719983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.
    Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK
    Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.
    Qawasmi M; Samuh M; Glebe D; Gerlich WH; Azzeh M
    Hum Vaccin Immunother; 2015; 11(7):1717-24. PubMed ID: 25996579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
    Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
    JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.